Company intelligence / Profile preview
Tibet Ganlu Tibetan Medicine
Xizang Zizhiqu, Chinaglzy.cn ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The company has at least one approved product ("Cuitang Pills") for the common cold on the Chinese market since October 2020. It focuses on traditional Tibetan herbal medicines with some clinical and ethnopharmacological research published. No advanced Western-style clinical trial data available publicly.
- Therapeutic areas
- PulmonologyInfectious Diseases
- Modalities
- Herbal medicine
- Industry
- Biotech
02
Drug pipeline
24 assets23 more assets in the full pipeline.
03
Partnerships
None publicly disclosed
Beyond the preview
Go deeper on Tibet Ganlu Tibetan Medicine.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tibet Ganlu Tibetan Medicine.